KTKai Sen Tan

Kai Sen Tan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kai Sen Tan has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Anand Andiappan

    Singapore Immunology Network, A*STAR, Singapore, Singapore

    1 shared publication
  • Bernett Lee

    Singapore Immunology Network, A*STAR, Singapore, Singapore

    1 shared publication
  • De Yun Wang

    Department of Otolaryngology, National University of Singapore, Singapore, Singapore

    1 shared publication
  • De Yun Wang

    Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    1 shared publication
  • Jing Liu

    Department of Otolaryngology, National University of Singapore, Singapore, Singapore

    1 shared publication
  • Jing Liu

    Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore

    1 shared publication

Latest Publications

  • RNA sequencing revealed transcriptomic changes of the human nasal epithelium following human influenza infection

    by Kai Sen Tan, Anand Andiappan, Bernett Lee, Yan Yan, Jing Liu, Olaf Rotzschke, Vincent Chow, De Yun Wang

    Background: With the advent of RNA sequencing technology, we are able to study host transcriptomic changes in more detail. The objective of the study is to further build on the model to query for transcriptomic changes using RNA sequencing of the influenza infected human nasal epithelium. Method: We performed increased number of samples with RNA sequencing from different healthy donors to establish the common nasal signatures post human influenza infection. We performed differential gene analysis followed by pathway gene set enrichment analysis to elucidate the key changes occurring in the nasal epithelium following infection. Results: With RNA sequencing, we profile an increased number of significantly differentially expressed genes from the nasal epithelium and identified and verified additional transcripts tied to the immune responses against human influenza infection. The immune pathways were largely tied to viral response, interferon pathway, MAPK pathway and NFκB pathway. We also performed focused analysis on non-immune response transcripts to identify key non-immune pathways found unique to the nasal epithelium, the primary site of influenza infection. Pathways found to be differentially regulated include apoptotic, responses to fatty acid and organic cyclic compound metabolism. Conclusion: In conclusion, RNA sequencing analysis of human influenza infected nasal epithelium revealed early response pathways of the nasal epithelium against influenza virus infection, and may be used as a healthy baseline comparator for target discovery as well as comparing with influenza infection with underlying chronic inflammatory airway conditions.

  • Open Access

    Upregulation of cell-surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection

    by Zhuang Gui Chen, Zhao Ni Wang, Yan Yan, Jing Liu, Ting Ting He, Kim Thye Thong, Yew Kwang Ong, Vincent T. K. Chow, Kai Sen Tan, De Yun Wang

    Cell-surface mucins are expressed in apical epithelial cells of the respiratory tract, and contribute a crucial part of the innate immune system. Despite anti-inflammatory or antiviral functions being revealed for certain cell-surface mucins such as MUC1, the roles of other mucins are still poorly understood, especially in viral infections. To further identify mucins significant in influenza infection, we screened the expression of mucins in human nasal epithelial cells infected by H3N2 influenza A virus. We found that the expression of MUC15 was significantly upregulated upon infection, and specific only to active infection. While MUC15 did not interact with virus particles or reduce viral replication directly, positive correlations were observed between MUC15 and inflammatory factors in response to viral infection. Given that the upregulation of MUC15 was only triggered late into infection when immune factors (including cytokines, chemokines, EGFR and phosphorylated ERK) started to peak and plateau, MUC15 may potentially serve an immunomodulatory function later during influenza viral infection. Our study revealed that MUC15 was one of the few cell-surface mucins induced during influenza infection. While MUC15 did not interact directly with influenza virus, we showed that its increase coincides with the peak of immune activation and thus MUC15 may serve an immunomodulatory role during influenza infection.